Drugs Made In America Acquisition (DMIIR) Common Equity (2024 - 2026)
Drugs Made In America Acquisition (DMIIR) posted quarterly Common Equity of -$17.8 million for Q4 2025, down 15128.73% year-over-year from N/an in Q4 2024, and down 2.86% quarter-over-quarter from -$17.3 million in Q3 2025.
Analysis
Drugs Made In America Acquisition (DMIIR) Common Equity (2024 - 2026) Analysis & Trends
Drugs Made In America Acquisition (DMIIR) has reported Common Equity for 2 consecutive years, with -$17.8 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Common Equity fell 15128.73% year-over-year to -$17.8 million; the TTM figure through Dec 2025 stood at -$17.8 million (down 15128.73% YoY), while the FY2025 annual figure was -$17.8 million, down 15128.73% from the prior year.
- Common Equity fell to -$17.8 million in Q4 2025 per DMIIR's latest filing, from -$17.3 million in the prior quarter.
- Across five years, Common Equity topped out at -$116719.0 in Q4 2024 and bottomed at -$17.8 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Cluster Group Holdings | 8.00 Bn | 8.00 Bn | - | -76,013.00 |
| 2 | Agriculture & Natural Solutions Acquisition | 853.42 Mn | 853.17 Mn | - | -34.15 Mn |
| 3 | K&F Growth Acquisition | 836.15 Mn | 836.15 Mn | - | -9.85 Mn |
| 4 | Armada Acquisition | 666.54 Mn | 666.49 Mn | - | -14.53 Mn |
| 5 | Pioneer Acquisition I | 652.74 Mn | 652.27 Mn | - | -11.79 Mn |
| 6 | Oxley Bridge Acquisition | 652.11 Mn | 652.11 Mn | - | -11.21 Mn |
| 7 | Titan Acquisition | 651.43 Mn | 941.85 Mn | - | -14.14 Mn |
| 8 | GSR IV Acquisition | 622.22 Mn | 622.22 Mn | - | -7.94 Mn |
| 9 | Launch One Acquisition | 618.70 Mn | 618.70 Mn | - | -12.62 Mn |
| 10 | Drugs Made In America Acquisition | 5.10 Mn | 5.10 Mn | - | -17.93 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -17.93 Mn |
| Dec 31, 2025 | -17.77 Mn |
| Sep 30, 2025 | -17.28 Mn |
| Dec 31, 2024 | -116,719.00 |